The Differential Role of Central and Bridge Symptoms in Deactivating Psychopathological Networks.
bridge symptoms
central symptoms
network analysis
psychopathology
vulnerability
Journal
Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902
Informations de publication
Date de publication:
2019
2019
Historique:
received:
29
01
2019
accepted:
15
10
2019
entrez:
13
12
2019
pubmed:
13
12
2019
medline:
13
12
2019
Statut:
epublish
Résumé
The network model of psychopathology suggests that central and bridge symptoms represent promising treatment targets because they may accelerate the deactivation of the network of interactions between the symptoms of mental disorders. However, the evidence confirming this hypothesis is scarce. This study re-analyzed a convenience sample of 51 cross-sectional psychopathological networks published in previous studies addressing diverse mental disorders or clinically relevant problems. In order to address the hypothesis that central and bridge symptoms are valuable treatment targets, this study simulated five distinct attack conditions on the psychopathological networks by deactivating symptoms based on two characteristics of central symptoms (degree and strength), two characteristics of bridge symptoms (overlap and bridgeness), and at random. The differential impact of the characteristics of these symptoms was assessed in terms of the magnitude and the extent of the attack required to achieve a maximum impact on the number of components, average path length, and connectivity. Only moderate evidence was obtained to sustain the hypothesis that central and bridge symptoms constitute preferential treatment targets. The results suggest that the degree, strength, and bridgeness attack conditions are more effective than the random attack condition only in increasing the number of components of the psychopathological networks. The degree attack condition seemed to perform better than the strength, bridgeness, and overlap attack conditions. Overlapping symptoms evidenced limited impact on the psychopathological networks. The need to address the basic mechanisms underlying the structure and dynamics of psychopathological networks through the expansion of the current methodological framework and its consolidation in more robust theories is stressed.
Identifiants
pubmed: 31827450
doi: 10.3389/fpsyg.2019.02448
pmc: PMC6849493
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2448Informations de copyright
Copyright © 2019 Castro, Ferreira, de Castro, Rodrigues, Correia, Ribeiro and Ferreira.
Références
Nature. 2005 Jun 9;435(7043):814-8
pubmed: 15944704
Behav Res Methods. 2018 Feb;50(1):195-212
pubmed: 28342071
Psychol Med. 2016 Dec;46(16):3359-3369
pubmed: 27623748
J Abnorm Child Psychol. 2017 Jan;45(1):83-90
pubmed: 27017822
Int J Eat Disord. 2018 Mar;51(3):214-222
pubmed: 29451959
J Abnorm Psychol. 2017 Apr;126(3):340-354
pubmed: 28277735
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Soc Psychiatry Psychiatr Epidemiol. 2018 Jun;53(6):617-627
pubmed: 29627898
PLoS One. 2010 Sep 02;5(9):
pubmed: 20824084
Behav Res Ther. 2017 Oct;97:213-221
pubmed: 28826067
J Abnorm Psychol. 2015 May;124(2):256-65
pubmed: 25730514
J Anxiety Disord. 2016 Oct;43:70-78
pubmed: 27637074
PLoS One. 2019 Jan 18;14(1):e0211053
pubmed: 30657783
J Abnorm Psychol. 2018 Feb;127(2):251-264
pubmed: 29528678
Phys Rev E Stat Nonlin Soft Matter Phys. 2002 Dec;66(6 Pt 2):065102
pubmed: 12513335
PLoS One. 2011;6(11):e27407
pubmed: 22114671
JAMA Psychiatry. 2017 Feb 1;74(2):135-142
pubmed: 28002832
Psychother Psychosom. 2016;85(2):114-6
pubmed: 26821231
PLoS One. 2015 Sep 14;10(9):e0137621
pubmed: 26368008
Psychother Psychosom. 2017;86(3):175-177
pubmed: 28490028
Nature. 1998 Jun 4;393(6684):440-2
pubmed: 9623998
Psychol Med. 2017 Dec;47(16):2767-2776
pubmed: 28625186
Clin Psychol Sci. 2018 May;6(3):335-351
pubmed: 29881651
Psychol Methods. 2018 Dec;23(4):617-634
pubmed: 29595293
Psychother Psychosom. 2019;88(2):71-83
pubmed: 30889609
Clin Psychol Sci. 2015 Mar;3(2):292-300
pubmed: 31754552
JAMA Psychiatry. 2015 Dec;72(12):1219-26
pubmed: 26561400
J Psychiatr Res. 2019 Feb;109:52-58
pubmed: 30502492
J Affect Disord. 2019 Sep 1;256:295-301
pubmed: 31200167
Phys Rev E Stat Nonlin Soft Matter Phys. 2002 May;65(5 Pt 2):056109
pubmed: 12059649
Multivariate Behav Res. 2018 Jul-Aug;53(4):453-480
pubmed: 29658809
Psychol Med. 2019 Jan;49(2):314-324
pubmed: 29655386
Psychiatry Res. 2018 Apr;262:270-281
pubmed: 29477070
Behav Res Ther. 2019 May;116:69-79
pubmed: 30831478
Trends Biochem Sci. 2008 Dec;33(12):569-76
pubmed: 18945619
World Psychiatry. 2017 Feb;16(1):5-13
pubmed: 28127906
J Affect Disord. 2019 May 1;250:85-93
pubmed: 30836284
Annu Rev Clin Psychol. 2013;9:91-121
pubmed: 23537483
J Affect Disord. 2017 Jan 15;208:490-496
pubmed: 27810269
Depress Anxiety. 2020 Feb;37(2):115-124
pubmed: 31710772
Behav Res Ther. 2017 Nov;98:19-38
pubmed: 28577757
Psychol Assess. 2016 Nov;28(11):1354-1367
pubmed: 26821198
Arch Gen Psychiatry. 2005 Jun;62(6):617-27
pubmed: 15939839
PLoS One. 2017 Oct 17;12(10):e0186695
pubmed: 29040324
Nature. 2000 Jul 27;406(6794):378-82
pubmed: 10935628
PLoS One. 2016 Dec 8;11(12):e0167490
pubmed: 27930698
Soc Psychiatry Psychiatr Epidemiol. 2017 Mar;52(3):329-339
pubmed: 28013328
Psychiatry Res. 2019 Jan;271:640-648
pubmed: 30791337
PLoS One. 2014 Nov 26;9(11):e112734
pubmed: 25427156
Soc Psychiatry Psychiatr Epidemiol. 2015 Jan;50(1):1-5
pubmed: 24970576
Bioinformatics. 2006 Apr 15;22(8):1021-3
pubmed: 16473872
Schizophr Res. 2018 Mar;193:232-239
pubmed: 28844638
PLoS One. 2017 Jun 1;12(6):e0178586
pubmed: 28570696
Sci Rep. 2017 Apr 20;7:46523
pubmed: 28425449
J Autism Dev Disord. 2020 May;50(5):1580-1595
pubmed: 30778821
J Abnorm Psychol. 2019 Nov;128(8):892-903
pubmed: 31318245
Eur Eat Disord Rev. 2019 Jan;27(1):24-33
pubmed: 30062717
Eur J Psychotraumatol. 2017 Jun 02;8(sup3):1333387
pubmed: 29038689
PLoS One. 2015 Oct 27;10(10):e0141420
pubmed: 26505477
Behav Brain Sci. 2018 Jan 24;42:e2
pubmed: 29361992
Perspect Psychol Sci. 2016 Sep;11(5):597-605
pubmed: 27694457
Psychother Psychosom. 2019;88(1):52-54
pubmed: 30625483
J Affect Disord. 2019 Apr 15;249:270-277
pubmed: 30784724
Behav Brain Sci. 2010 Jun;33(2-3):137-50; discussion 150-93
pubmed: 20584369
Sci Rep. 2019 May 2;9(1):6846
pubmed: 31048731
Br J Psychiatry. 2019 Jun;214(6):361-368
pubmed: 30621797
Sci Rep. 2014 Aug 01;4:5918
pubmed: 25082149
JAMA Psychiatry. 2018 Jan 1;75(1):98-100
pubmed: 29188277
J Consult Clin Psychol. 2018 Oct;86(10):831-844
pubmed: 30265042
J Abnorm Psychol. 2014 Aug;123(3):510-22
pubmed: 24933281
Sci Rep. 2018 Apr 11;8(1):5854
pubmed: 29643399
Psychol Med. 2017 May;47(7):1204-1214
pubmed: 28052778
BMC Med. 2015 Apr 06;13:72
pubmed: 25879936
Bioinformatics. 2012 Aug 15;28(16):2202-4
pubmed: 22718784
J Adolesc. 2017 Dec;61:12-16
pubmed: 28910672
Soc Psychiatry Psychiatr Epidemiol. 2017 Jan;52(1):1-10
pubmed: 27921134
J Affect Disord. 2018 Feb;227:739-744
pubmed: 29179144
Multivariate Behav Res. 2021 Mar-Apr;56(2):353-367
pubmed: 31179765
Res Nurs Health. 2017 Jun;40(3):218-228
pubmed: 28220506
Psychol Rev. 2018 Jul;125(4):606-615
pubmed: 29952625
Psychother Psychosom. 2016;85(3):183-4
pubmed: 27043457
Perspect Psychol Sci. 2013 Nov;8(6):651-62
pubmed: 26173229
JAMA Psychiatry. 2018 Nov 1;75(11):1173-1181
pubmed: 30128480
Psychol Med. 2016 Oct;46(14):2989-2998
pubmed: 27523095
PLoS One. 2016 Nov 23;11(11):e0155205
pubmed: 27880771
J Autism Dev Disord. 2015 Oct;45(10):3115-32
pubmed: 26206232
J Consult Clin Psychol. 2017 Dec;85(12):1158-1170
pubmed: 29189032
J Abnorm Psychol. 2016 Aug;125(6):747-57
pubmed: 27505622
Multivariate Behav Res. 2021 Mar-Apr;56(2):199-223
pubmed: 31401872
J Autism Dev Disord. 2015 Jan;45(1):192-202
pubmed: 25149176
J Affect Disord. 2016 Jan 1;189:314-20
pubmed: 26458184
Perspect Psychol Sci. 2018 Sep;13(5):549-566
pubmed: 30213257
Phys Rev Lett. 2001 Nov 5;87(19):198701
pubmed: 11690461